Clinical Trial Update: Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating dapagliflozin in hypotensive heart failure patients after sacubitril/valsartan therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypotension

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Cheng-Hsin General Hospital | Conditions: Hypotension, Heart Failure | Phase 4 | Status: COMPLETED